Martin Ungerer
Overview
Explore the profile of Martin Ungerer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeitrag J, Benedicic M, Wolf J, Ammon T, Mayr V, Holthoff H, et al.
Biochim Biophys Acta Mol Basis Dis
. 2025 Mar;
1871(5):167747.
PMID: 40024060
Background: Graves' disease (GD) and orbitopathy (GO) are common systemic autoimmune diseases targeting the human thyrotropin receptor. We carried out detailed immune cell investigations in GD/GO. Methods And Results: For...
2.
Ammon T, Zeitrag J, Mayr V, Benedicic M, Holthoff H, Ungerer M
ACR Open Rheumatol
. 2025 Jan;
7(1):e11785.
PMID: 39846262
Objective: Rheumatoid arthritis (RA) is characterized by circulating anti-cyclic citrullinated peptide (CCP) autoantibodies (ACPAs), resulting in inflammation of the joints and other organs. We have established novel assays to assess...
3.
Chen Z, Gengenbach U, Koker L, Huang L, Mach T, Reichert K, et al.
Small
. 2023 Dec;
20(21):e2306865.
PMID: 38126669
Functional inks enable manufacturing of flexible electronic devices by means of printing technology. Silver nanoparticle (Ag NP) ink is widely used for printing conductive components. A sintering process is required...
4.
Klupfel J, Passreiter S, Rumpf M, Christa C, Holthoff H, Ungerer M, et al.
Anal Bioanal Chem
. 2022 Nov;
415(3):391-404.
PMID: 36346456
The SARS-CoV-2 pandemic has shown the importance of rapid and comprehensive diagnostic tools. While there are numerous rapid antigen tests available, rapid serological assays for the detection of neutralizing antibodies...
5.
Richardson J, Gotz R, Mayr V, Lohse M, Holthoff H, Ungerer M
PLoS One
. 2022 Apr;
17(4):e0266701.
PMID: 35468147
Objective: We investigated blood samples from fully SARS-CoV2-vaccinated subjects and from previously positive tested patients up to one year after infection with SARS-CoV2, and compared short- and long-term T cell...
6.
Klupfel J, Passreiter S, Weidlein N, Knopp M, Ungerer M, Protzer U, et al.
Anal Chem
. 2022 Feb;
94(6):2855-2864.
PMID: 35107016
Lateral-flow immunoassays and laboratory diagnostic tests like enzyme-linked immunosorbent assays (ELISAs) are powerful diagnostic tools to help fight the COVID-19 pandemic using them as antigen or antibody tests. However, the...
7.
Wenhart C, Holthoff H, Reimann A, Li Z, Fassbender J, Ungerer M
Sci Rep
. 2021 Aug;
11(1):17345.
PMID: 34462464
Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease which affects primarily the joints. Peptides of several proteins have shown an effect in some experimental animal models of RA. We...
8.
Li Z, Ungerer M, Fassbender J, Wenhart C, Holthoff H, Muench G
PLoS One
. 2021 Aug;
16(8):e0255363.
PMID: 34347814
The standard histological processing procedure, which produces excellent staining of sections for most tissues, fails to yield satisfactory results in adult mouse orbits or eyeballs. Here, we show that a...
9.
Diana T, Ungerer M, Wuster C, Fassbender J, Li Z, Reimann A, et al.
J Autoimmun
. 2021 Jun;
122:102666.
PMID: 34144327
Background: BALB/c mice which received long-term immunizations of adenovirus (Ad) expressing thyrotropin receptor A-subunits (TSHR) developed stable Graves' disease (GD). TSHR-derived cyclic peptide 19 (P19) was identified as effective therapy...
10.
Klupfel J, Koros R, Dehne K, Ungerer M, Wurstle S, Mautner J, et al.
Anal Bioanal Chem
. 2021 May;
413(22):5619-5632.
PMID: 33983466
In the face of the COVID-19 pandemic, the need for rapid serological tests that allow multiplexing emerged, as antibody seropositivity can instruct about individual immunity after an infection with SARS-CoV-2...